Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
349 EUR | +0.72% | -7.18% | -2.92% |
Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated | |
Apr. 17 | Virbac: sales up by almost 10% in Q1 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.92% | 3.12B | |
-19.73% | 72.39B | |
-11.01% | 6.54B | |
+15.88% | 3.43B | |
-0.68% | 1.4B | |
-17.27% | 1.34B | |
-2.73% | 1.26B | |
-14.67% | 1.12B | |
-5.37% | 990M | |
-24.06% | 805M |
- Stock Market
- Equities
- VIRP Stock
- News Virbac
- Stifel Keeps Virbac at Hold, Boosts PT